These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7899347)

  • 21. Gastroenteritis and antibiotic-associated diarrhea.
    Jabbar A; Wright RA
    Prim Care; 2003 Mar; 30(1):63-80, vi. PubMed ID: 12825250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Old dogmas and new perspectives in antibiotic-associated diarrhea].
    Cramer JP; Burchard GD; Lohse AW
    Med Klin (Munich); 2008 May; 103(5):325-38; quiz 339-40. PubMed ID: 18484219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diarrhoea associated with antibiotic use.
    McFarland LV
    BMJ; 2007 Jul; 335(7610):54-5. PubMed ID: 17626915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who are susceptible to pseudomembranous colitis among patients with presumed antibiotic-associated diarrhea?
    Lee KS; Shin WG; Jang MK; Kim HS; Kim HS; Park CJ; Lee JY; Kim KH; Park JY; Lee JH; Kim HY; Cho SJ; Yoo JY
    Dis Colon Rectum; 2006 Oct; 49(10):1552-8. PubMed ID: 17028914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. John G. Bartlett: Contributions to the discovery of Clostridium difficile antibiotic-associated diarrhea.
    Gorbach SL
    Clin Infect Dis; 2014 Sep; 59 Suppl 2():S66-70. PubMed ID: 25151480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment.
    Mitty RD; LaMont JT
    Gastroenterologist; 1994 Mar; 2(1):61-9. PubMed ID: 8055233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.
    Hickson M; D'Souza AL; Muthu N; Rogers TR; Want S; Rajkumar C; Bulpitt CJ
    BMJ; 2007 Jul; 335(7610):80. PubMed ID: 17604300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
    Kotowska M; Albrecht P; Szajewska H
    Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between Lactobacilli and antibiotic-associated diarrhea.
    Naaber P; Mikelsaar M
    Adv Appl Microbiol; 2004; 54():231-60. PubMed ID: 15251283
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clostridium difficile-associated diarrhea--an increasing problem. Reduce the administration of antibiotics and improve hygiene!].
    Svenungsson B
    Lakartidningen; 1996 Aug; 93(35):2931-4. PubMed ID: 8815352
    [No Abstract]   [Full Text] [Related]  

  • 32. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic-associated diarrhea and Clostridium difficile colitis: an update.
    Giannella RA
    Rev Esp Enferm Dig; 2001 Aug; 93(8):535-43. PubMed ID: 11692783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
    Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
    J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice.
    Elmer GW; Corthier G
    Can J Microbiol; 1991 Apr; 37(4):315-7. PubMed ID: 1913342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii.
    Kimmey MB; Elmer GW; Surawicz CM; McFarland LV
    Dig Dis Sci; 1990 Jul; 35(7):897-901. PubMed ID: 2364845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection.
    Flatley EA; Wilde AM; Nailor MD
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):21-4. PubMed ID: 25822430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic-associated diarrhea].
    Beaugerie L
    Rev Prat; 2008 Jun; 58(11):1207-12. PubMed ID: 18689117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.